Literature DB >> 30256152

Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae.

Scott D Kobayashi1, Frank R DeLeo1.   

Abstract

Entities:  

Keywords:  antibiotic resistance; antibody; carbapenem; innate immunity; vaccine

Mesh：

Substances：

Year:  2018        PMID： 30256152      PMCID： PMC6190217          DOI： 10.2217/fmb-2018-0189

Source DB:  PubMed          Journal:  Future Microbiol        ISSN： 1746-0913            Impact factor:   3.165


× No keyword cloud information.
  19 in total

1.  Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae.

Authors:  Frank R Deleo; Liang Chen; Stephen F Porcella; Craig A Martens; Scott D Kobayashi; Adeline R Porter; Kalyan D Chavda; Michael R Jacobs; Barun Mathema; Randall J Olsen; Robert A Bonomo; James M Musser; Barry N Kreiswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

2.  Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4.

Authors:  Taylor S Cohen; Mark Pelletier; Lily Cheng; Meghan E Pennini; Jessica Bonnell; Romana Cvitkovic; Chew-Shun Chang; Xiaodong Xiao; Elisabetta Cameroni; Davide Corti; Elena Semenova; Paul Warrener; Bret R Sellman; JoAnn Suzich; Qun Wang; C Kendall Stover
Journal:  JCI Insight       Date:  2017-05-04

3.  Importance of Clonal Complex 258 and IncFK2-like Plasmids among a Global Collection of Klebsiella pneumoniae with blaKPC.

Authors:  Gisele Peirano; Patricia A Bradford; Krystyna M Kazmierczak; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.

Authors:  Michael J Satlin; Liang Chen; Gopi Patel; Angela Gomez-Simmonds; Gregory Weston; Angela C Kim; Susan K Seo; Marnie E Rosenthal; Steven J Sperber; Stephen G Jenkins; Camille L Hamula; Anne-Catrin Uhlemann; Michael H Levi; Bettina C Fries; Yi-Wei Tang; Stefan Juretschko; Albert D Rojtman; Tao Hong; Barun Mathema; Michael R Jacobs; Thomas J Walsh; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 5.  Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria.

Authors:  Kelly L Wyres; Kathryn E Holt
Journal:  Curr Opin Microbiol       Date:  2018-05-01       Impact factor: 7.934

6.  Multiplex PCR for identification of two capsular types in epidemic KPC-producing Klebsiella pneumoniae sequence type 258 strains.

Authors:  Liang Chen; Kalyan D Chavda; Jacqueline Findlay; Gisele Peirano; Katie Hopkins; Johann D D Pitout; Robert A Bonomo; Neil Woodford; Frank R DeLeo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

7.  Phagocytosis and Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils.

Authors:  Scott D Kobayashi; Adeline R Porter; David W Dorward; Amanda J Brinkworth; Liang Chen; Barry N Kreiswirth; Frank R DeLeo
Journal:  J Infect Dis       Date:  2016-01-14       Impact factor: 5.226

8.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

9.  Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.

Authors:  Matthew E Falagas; Giannoula S Tansarli; Drosos E Karageorgopoulos; Konstantinos Z Vardakas
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

10.  Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection.

Authors:  Elizabeth Diago-Navarro; Michael P Motley; Gonzalo Ruiz-Peréz; Winnie Yu; Julianne Austin; Bruna M S Seco; Guozhi Xiao; Aniska Chikhalya; Peter H Seeberger; Bettina C Fries
Journal:  mBio       Date:  2018-04-03       Impact factor: 7.867
View more
  2 in total

1.  Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae.

Authors:  Julian R Braxton; Carlos A Rodriguez-Osorio; Anna P Zagieboylo; Christoph M Ernst; Li Li; Alejandro Pironti; Abigail L Manson; Anil V Nair; Maura Benson; Kaelyn Cummins; Anne E Clatworthy; Ashlee M Earl; Lisa A Cosimi; Deborah T Hung
Journal:  Nat Med       Date:  2020-04-13       Impact factor: 87.241

Review 2.  Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections.

Authors:  Isabelle Bekeredjian-Ding
Journal:  Front Immunol       Date:  2020-08-05       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.